Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has informed BSE that its Board of Directors will meet on Tuesday, 02 September 2025 at the registered office in Mumbai. The main agenda is to finalise and approve matters related to its 33rd Annual General Meeting (AGM) for the financial year ended 31 March 2025. Key items include fixing the day, date, time and mode of the AGM, approving the draft notice and calendar of events, and setting the cut-off date and e-voting window for members. The board will also consider and approve the Directors' Report and Annual Report for FY 2024-25, approve the closure of the Share Transfer Books and Register of Members, and appoint a scrutinizer for the e-voting process. The intimation has been filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, 2015.
This is a routine procedural filing related to the upcoming AGM and there is no material business or financial impact on shareholders. Investors should look out for the AGM notice and Annual Report, which will contain the company's financial performance details for FY 2024-25.